University Hospitals has received American Heart Association Get With The Guidelines - Stroke awards for its commitment to ensuring timely, appropriate treatment for stroke patients. The hospital has achieved high levels of quality care, including door-to-needle times of 45 minutes or less for 75% of patients.
The program supports junior investigators and established researchers, fostering mentorship, scientific innovation, and interdisciplinary collaboration. The funded projects focus on various areas, including neurorestorative cell therapy, eliminating therapy-induced senescent cells, and microbiome-immune-radiation interactome in prostat...
A new study from University Hospitals Cleveland Medical Center found that women with chronic pain conditions or a history of recurrent pregnancy loss were more likely to use Whole Systems Traditional Chinese Medicine during IVF. The study also identified higher-income neighborhoods and prior ART cycles as factors associated with WS-TCM...
Dr. Sepideh Amin-Hanjani, MD, FAANS, has been elected President-elect of the American Association of Neurological Surgeons (AANS), while Dr. Nicholas C. Bambakidis, MD, will become President-elect of the Society of Neurological Surgeons in 2027.
The University Hospitals and Clasp student loan repayment program offers up to $20,000 in employer-sponsored support for new graduate Radiologic professionals and Respiratory Therapists. The program aims to reduce financial barriers to education and attract top talent to the region.
Researchers have created a new approach to cancer vaccine design by leveraging pre-existing antiviral immune memories. PROTEXI, a dendritic cell vaccine platform, converts dormant antiviral memory into a catalyst for antitumor immunity, slowing tumor growth and improving survival in multiple preclinical models.
The study demonstrated significant clinical benefits for patients, with single treatments leading to meaningful reductions in moderate-to-severe symptoms. Patient satisfaction was exceptionally high throughout the program, with over 80% strongly agreeing they were satisfied with the services.
Researchers have identified a promising drug to treat neurodegenerative conditions, including Alzheimer's disease and traumatic brain injury. The study found that inhibition of an enzyme called 15-PGDH was potently neuroprotective by restraining the production of reactive oxygen species that damage the brain.
Brian Adams, newly appointed Chief Operating Officer of UH Portage Medical Center, brings a deep understanding of clinical care and a commitment to supporting patients and care teams. With over 20 years of service at University Hospitals, Adams' leadership style is informed by his time at the bedside.
The project aims to expand University Hospitals' collaborative care model from 26 practices to all 88 practices within the UH Primary Care Institute. It will also broaden services to include screening and treatment for conditions such as bipolar disorder and post-traumatic stress disorder (PTSD).
The CDL Healthcare Delivery stream will support early-stage ventures building technology to reduce costs, improve patient outcomes, and accelerate innovation in real clinical environments. Founders will have access to University Hospitals as a living laboratory, testing their technologies with clinicians and caregivers.
Cleveland researchers found that nitric oxide levels are decreased in Alzheimer's brains and correlate with worse clinical outcomes. Targeting enzymes to restore nitric oxide levels could represent a new therapeutic strategy for treating the disease.
Researchers from Harrington Discovery Institute provide a new understanding of cancer processes and identify promising targets for treatments. They uncover a class of therapeutic targets that may complement existing therapies.
Surgical patients with mental health and/or substance use disorders who receive music therapy have a 41.8% longer length of stay compared to those without music therapy. They also exhibit increased resource-intensive admissions, anxiety, trauma/stress-related disorders, and heart failure.
The new program addresses unique challenges faced by female athletes, including injury prevention, hormonal health, pelvic floor issues, and heart health. It offers coordinated care through a team of experts in orthopedic sports medicine, primary care, and other specialties.
University Hospitals is the first US health system to achieve ISO 9001 certification for its corporate headquarters and the first in Ohio with all hospitals certified. The achievement demonstrates a systemwide commitment to consistency, accountability, and continuous improvement.
A new study found that pediatric patients with long-COVID experience a high symptom burden, including sleep disturbance, anxiety, depression, and fatigue. The study describes an interdisciplinary care approach that incorporates integrative medicine, nutrition, and lifestyle modifications to manage symptoms.
Researchers at University Hospitals Cleveland Medical Center have introduced a new, non-invasive treatment option for patients with refractory ventricular tachycardia, a life-threatening heart condition. The therapy uses precision-targeted radiation to neutralize damaged heart tissue and is offered at select centers worldwide.
A new study by University Hospitals Harrington Heart & Vascular Institute highlights the long-term impact of preventive heart and vascular care. The study shows a significant decline in cardiovascular mortality rates after investments in local cardiac care, with notable reductions among older age groups.
The S2419 BioFront study aims to enroll over 700 patients with advanced renal cell carcinoma and test the safety and efficacy of a CBM588 capsule as part of an immunotherapy-based treatment. The trial seeks to improve outcomes for patients by leveraging the gut microbiome.
University Hospitals has been recognized by RLDatix for its streamlined policy management and integrated compliance systems, transforming how regulatory information is managed. This recognition highlights the organization's commitment to safety, care quality, and better outcomes for every patient.
Researchers found patients who retreated with docetaxel had longer overall survival and fewer supportive-care needs compared to those switching to cabazitaxel. The study provides evidence-based options for selected patients previously tolerated docetaxel.
UH Cleveland Medical Center ranked seventh in US and 15th globally as strongest academic medical center brand. The hospital received recognition for patient treatment, medical research, training, and education.
A new study published in Redox Biology found that an experimental neuroprotective drug called P7C3-A20 can prevent the negative side effects of whole brain radiotherapy, including memory problems and depression. The drug was shown to reduce oxidative stress and protect nerve cells in mice with WBRT-induced brain damage.
A recent study from University Hospitals Cleveland Medical Center found that diagnostic abnormalities were no more likely to occur among adults with unintentional weight loss than among comparison patients. In most cases, the weight loss was not linked to a serious underlying condition, with only a .7% overall rate of cancer.
Kristie Ross, MD, MS, is promoted to Chief Medical Officer of UH Rainbow Babies & Children's, bringing over two decades of experience in leadership and clinical expertise. Dr. Ross has made significant contributions to research, education, and quality improvement initiatives.
Researchers from University Hospitals Seidman Cancer Center found that the optimal duration of hormone therapy for prostate cancer treatment varies by disease risk. For high-risk patients, longer courses of ADT provide diminishing benefits while increasing the risk of non-prostate cancer death.
Researchers at UH Seidman Cancer Center have developed a reliable tool to predict early biochemical response in metastatic hormone-sensitive prostate cancer patients. This framework enables clinicians to identify high-risk patients at diagnosis, guide early treatment discussions, and potentially improve patient outcomes.
Pediatric faculty members Michael Dell, Ross Myers, and Samudragupta Bora were elected to the American Pediatric Society for their exceptional contributions to clinical care, education, and research. The American Pediatric Society is a leading academic pediatric organization that has advanced child health for over 130 years.
Researchers have successfully reversed Alzheimer's disease in animal models by restoring the brain's energy balance, leading to both pathological and functional recovery. The study used preclinical mouse models and human AD brains to show that maintaining proper NAD+ levels can prevent and even reverse the disease.
Researchers at University Hospitals and Case Western Reserve University have discovered a novel enzyme, SCoR2, that removes nitric oxide from proteins controlling fat build-up. Inhibition of this enzyme prevents weight gain and liver injury in mouse models, also lowering bad cholesterol.
UH Cleveland Medical Center has achieved Magnet status for nursing excellence for the fifth consecutive time, a prestigious honor reserved for fewer than 2 percent of the nation's hospitals. The hospital's commitment to high-quality patient care and exceptional nursing practice is validated by this recognition.
Trigeminal neuralgia is a debilitating condition causing sudden, severe electric shock-like pain in the face. University Hospitals has successfully treated two initial patients with the OneRF Trigeminal Nerve Ablation System, providing complete pain relief without complications. The minimally-invasive procedure uses radiofrequency ener...
Cliff Megerian, MD, FACS, received the Sam Miller Goodness Award for his compassionate care, world-class research and relentless commitment to kindness. The Values-in-Action Foundation recognized UH's dedication to making Northeast Ohio a better place.
Zalunfiban, a next-generation GPIIb/IIIa inhibitor, met its efficacy and safety endpoints in treating STEMI patients. The drug was developed with support from Harrington Discovery Institute at University Hospitals, which provided advanced drug and business development support.
University Hospitals Cleveland Medical Center has received a top hospital safety grade of 'A' from the Leapfrog Group, demonstrating its commitment to zero harm and quality care. The hospital's Zero Harm initiatives have reduced infections, improved outcomes, and enhanced patient safety.
A new study suggests that chronological age should be considered when creating treatment plans for men with metastatic hormone-sensitive prostate cancer. Older patients are more likely to experience comorbid conditions and die from causes other than prostate cancer.
Sanjay Rajagopalan, a leading expert in cardiovascular medicine, has been recognized for his pioneering work on the impact of environmental risk factors on heart health. His research has informed public health policies worldwide and led to new understanding of how air pollution affects cardiovascular health.
The study found that patients with anxiety preferred non-drug treatments, such as cognitive reframing and breathing techniques. Pediatric integrative medicine services were shown to fill gaps in care for pediatric patients with complex conditions like long-COVID, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, and obesity.
Carol and John Fountain's $236 million gift will help sustain University Hospitals' community-focused mission. The South Pavilion at UH Ahuja Medical Center will be named in their honor, recognizing their transformative support.
A new multi-institutional study published in Health Science Reports found that adults with newly diagnosed low back pain who received spinal manipulative therapy administered by a chiropractor were significantly less likely to be diagnosed with opioid use disorder over a two-year follow-up compared to those prescribed ibuprofen. The st...
Kipum Lee, PhD, has been promoted to President of UH Ventures, succeeding David Sylvan. He will drive revenue growth and margin improvement through business opportunities aligned with UH's enterprise strategy.
A large study from University Hospitals Connor Whole Health found that recreative and music-assisted relaxation/imagery interventions were 37% and 48% more likely to reduce pain intensity than receptive only interventions. Longer sessions and explicit pain management goals also contributed to increased pain reduction.
The Improving Pediatric Sepsis Outcomes Collaborative has received the prestigious John M. Eisenberg Award, recognizing outstanding leadership and innovation in reducing pediatric sepsis mortality. The award highlights programs demonstrating impact, innovation, sustainability, replicability, and data-driven success.
The $3.5 million gift will enable the center to triple its patient capacity and expand into a new, 16,000-square-foot space, centralizing care for clinical trial patients. This expansion will bring potentially life-extending treatments to more patients than ever.
A new pilot study from University Hospitals Cleveland Medical Center found that music therapy improved pain after pancreatic surgery, supporting its feasibility and acceptability. The study also suggests continued use of music-assisted relaxation recordings over the course of hospitalization to further reduce post-operative symptoms.
University Hospitals has received American Heart Association quality achievement awards for ensuring stroke patients receive best practices and life-saving care. The institution prioritizes early detection and treatment to improve survival, minimize disability, and accelerate recovery times.
Researchers found measurable changes in brain signals responsible for motor control and movement after 12 dynamic cycling sessions. The study suggests long-term exercise programs could have wider restorative effects on the brain signals of Parkinson's Disease patients.
The tripartite agreement has driven $100M in NIH funding, 217 invention disclosures, 136 U.S. patents, and 31 international patents, accelerating MRI technology adoption and improving patient care. Technologies developed through this collaboration have shaped multiple FDA-approved products used worldwide.
The University Hospitals Seidman Cancer Center has become the first in the US to implement Akesis' Galaxy RTI device, advancing Stereotactic Radiosurgery (SRS) with enhanced precision and treatment efficiency. The center will also serve as a research hub for this innovative technology.